Cetuximab Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 5 mg/mL
Reference Brands: ERBITUX (USA/EU)
Category: Oncology Cancer Care
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor (EGFR), blocking its activation and slowing cancer cell growth. It is used in the treatment of metastatic colorectal cancer and squamous cell carcinoma of the head and neck. Cetuximab enhances the effect of chemotherapy and radiation therapy by inhibiting tumor cell proliferation. Marketed mainly under the brand name Erbitux, it is administered intravenously under medical supervision. Cetuximab is available in Injection and strengths such as 5 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cetuximab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Cetuximab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Cetuximab is used to treat certain types of cancer, including metastatic colorectal cancer and squamous cell carcinoma of the head and neck. It works by targeting the epidermal growth factor receptor (EGFR) on cancer cells, blocking their growth and proliferation. Cetuximab is often used in combination with chemotherapy or radiation therapy to enhance treatment effectiveness.
Cetuximab is made from a chimeric monoclonal antibody that specifically binds to the EGFR protein on the surface of cancer cells, inhibiting receptor activation and signaling pathways responsible for tumor growth.
The trade name of Cetuximab is Erbitux.
Cetuximab (Erbitux) is manufactured by Eli Lilly and Merck KGaA and distributed in multiple countries under regulatory approvals.
The generic name of Cetuximab is Cetuximab.
The brand name of Cetuximab is Erbitux.
Cetuximab is manufactured in the United States, Germany, and other approved facilities by Eli Lilly and Merck KGaA under strict GMP standards.
Related Products
Tafasitamab‑Cxix
Strength:
200 mg
Form: Injection
Reference Brands: Monjuvi (USA), Minjuvi (EU)
View Details
Dordaviprone Hydrochloride
Strength:
125 mg
Form: Capsules
Reference Brands: Modeyso (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
